SCHEMBL14727705

SCHEMBL14727705

C=C(C)C(=O)Oc1ccc(C(=O)Oc2ccc(C3(c4ccc(OC(=O)c5ccc(OC(=O)C(=C)C)cc5)cc4)CCC(CCC4CCC(CCCCC)CC4)CC3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.38
NPC1 O15118 2/20 0.37
LMNA P02545 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
GPR119 Q8TDV5 5/20 0.37
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PRSS1 P07477 1/20 0.35
ACR P10323 1/20 0.35
MAPT P10636 4/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14727684 0.94 KMT2A (0.38) ELANEGPR119KMT2AMEN1HPGD
SCHEMBL14727675 0.92 KMT2A (0.39) ELANEGPR119KMT2AMEN1HPGD
SCHEMBL14727703 0.90 GPR119 (0.36) ELANEGPR119KMT2A
SCHEMBL14727698 0.89 THRB (0.35) ELANEGPR119KMT2AMEN1
SCHEMBL14727683 0.88 THRB (0.44) ELANEGPR119KMT2AMEN1HPGD
SCHEMBL14478762 0.88 KMT2A (0.36) ELANEGPR119KMT2AMEN1HPGD
SCHEMBL14727682 0.87 KMT2A (0.36) ELANEGPR119KMT2AHPGD
SCHEMBL14727681 0.86 KMT2A (0.40) ELANELMNACYP2C9GPR119MAPT
SCHEMBL21074588 0.84 LSS (0.34) GPR119KMT2AMEN1HPGD
SCHEMBL14727697 0.83 THRB (0.34) ELANEGPR119KMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8840807-B2 Polymerizable compound JNC CORPORATION (JP) 2014-09-23 US disclosed
US-20130048912-A1 POLYMERIZABLE COMPOUND JNC PETROCHEMICAL CORPORATION (JP) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048912-A1 POLYMERIZABLE COMPOUND PYM1, ZYX, CPNE4 ELANE 2834/4885NPC1 1645/4885LMNA 877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.